On June 3, 2020, we attended an important strategic meeting in the field of biopharmaceuticals and cell and gene therapies. The event was originally planned in Boston, but due to the pandemic, it was conducted virtually. At the event, our technical director gave a presentation entitled “Benefits of modular automation in biopharmaceutical processes”.